CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Drospirenone /ethinyl estradiol

Last Updated: January 20, 2005
Result type: Reports
Project Number: SR0029-000
Product Line: Reimbursement Review

Generic Name: Drospirenone /ethinyl estradiol

Brand Name: Yasmin

Manufacturer: Berlex Canada Inc.

Therapeutic Area: Contraceptive, oral

Indications: Contraceptive, oral

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: June 16, 2005

Recommendation Type: List